Miguel Ángel Muñoz-Alía

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones et al. · Science · 2021 · 246 citations · Full text

Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins

Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Lianwen Zhang et al. · Cell Reports Medicine · 2021 · 52 citations · Full text

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>

Nir Drayman, Krysten A. Jones, Saara‐Anne Azizi et al. · 2020 · 41 citations · Full text

Antigenic Drift Defines a New D4 Subgenotype of Measles Virus

Miguel Ángel Muñoz-Alía, Claude P. Muller, Stephen J. Russell · Journal of Virology · 2017 · 23 citations · Full text

Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune Patients

Eugene S. Bah, Rebecca A. Nace, Kah Whye Peng et al. · Molecular Cancer Therapeutics · 2020 · 23 citations · Full text

Immunology, Viral Pathogenesis, Pathology +18